Antimicrobial |
method |
Estimated Creatinine Clearance (CrCl), ml/min |
||||
> 50-90 |
10-50 |
< 10 |
||||
Aminoglycosides |
||||||
Amikacin |
I |
7.5mg/kg q12h |
7.5mg/kg q24h |
7.5mg/kg q48h |
||
Gentamicin |
I |
1.7-2.0mg/kg q8h |
1.7-2.0mg/kg q12h-24h |
1.7-2.0mg/kg q8h |
||
|
|
CrCl 60-80 |
CrCl 40-60 |
CrCl 30-40 |
||
Gentamicin |
4 mg/kg q24h |
3.5 mg/kg q24h |
2.5 mg/kg q24h |
|||
Isepamicin |
8 mg/kg q24h |
8 mg/kg q24h |
8mg/kg q48h |
|||
Amikacin Streptomycin |
12 mg/kg q24h |
7.5 mg/kg q24h |
4 mg/kg q24h |
|||
Carbapenem |
||||||
Doripenem |
D, I |
500mg q8h |
30-50: 250mg q8h; 10-30: 250mg q12h |
No data |
||
Ertapenem |
D |
1g q24h |
<30: 0.5g q24h |
0.5g q24h |
||
Imipenem |
D, I |
250-500mg q6-8h |
250mg Q8-12h |
125-250mg q12h |
||
Meropenem |
D, I |
1 g q8h |
25-50: 1 g q12h; 10-25: 0.5g q12h |
0.5g q24h |
||
Cephalosporin, parenteral |
||||||
Cefazolin |
I |
1-2g q8h |
1-2g q12h |
1-2g q24-48h |
||
Cefepime |
D, I |
>60: 2g q8-12h |
30-60: 2g q12h 11-29: 2g q24h |
1g q24h |
||
Cefotaxime |
I |
2g q8-12h |
2q12-24h |
2g q24h |
||
Cefoxitin |
I |
2g q8h |
2g q8-12h |
2g q24-48h |
||
Ceftazidime |
I |
2g q8-12h |
2g q12-24h |
2g q24-q48h |
||
Ceftizoxime |
I |
2g q8h-12h |
2g q12h-24h |
2g q24h |
||
Ceftriaxone |
I |
1-2g q12-24h |
1-2g q12-24h |
1-2g q12-24h |
||
Cefuroxime |
I |
0.75-1.5g q8h |
0.75-1.5g q8-12h |
0.75-1.5g q24h |
||
Flouroquinolone |
||||||
Ciprofloxacin |
D |
400mg q12h |
400mg q24h |
400mg q24h |
||
Gemifloxacin |
D |
320mg q24h |
160mg q24h |
160mg q24h |
||
Levofloxacin |
D, I |
750mg q24h |
20-49: 750mg q48h |
< 20: 750mg once, then 500mg q48h |
||
Ofloxacin |
D |
200-400mg q12h |
200-400mg q24h |
200mg q24h |
||
Macrolide |
||||||
Clarithromycin |
D |
500mg q12h |
500mg q12-24h |
500mg q24h |
||
Erythromycin |
D |
100% |
100% |
50-75% |
||
Penicillins |
||||||
Ampicillin |
I |
1-2g q4-6h |
30-50 1-2g q6–8h 10-30: 1-2g q8-12h |
1-2g q12h |
||
Amoxicillin |
I |
250-500mg q8h |
250-500mg q8-12h |
250-500mg q24h |
||
Ampicillin/ Sulbactam |
I |
3g q6h |
3g q8-12h |
3g q24h |
||
Amoxicillin/ Clavulanate |
D, I |
500/125mg q8h |
250-500mg q12h (amox component) |
250-500mg q24h (amox) |
||
Piperacillin/ Tazobactam (non-pseudomonas dose) |
D, I |
>40: 3.375g q6h |
20-40: 2.25g q6h; < 20: 2.25g q8h |
2.25g q8h |
||
Piperacillin/ Tazobactam (pseudomonas dose) |
D, I |
>40: 4.5g q6h |
20-40: 3.375g q6h; < 20: 2.25g q6h |
2.25g q6h |
||
Ticarcillin |
D, I |
1-2gm q4h |
1-2gm q8h |
1-2gm q12h |
||
Tetracycline |
||||||
Tetracycline |
I |
250-500mg q8-12h |
250-500mg q12-24h |
250-500mg q24h |
||
Micellaneous Antibacterial |
||||||
Colistin base |
D, I |
Daily maintenance dose = 2.5*[(1.5*CrCln)+30] Divide and give q8h-12h, max 475mg/day CrCln = CrCl * (pt BSA /1.73 m2 ) |
||||
Daptomycin |
I |
4-6mg/kg/d |
30-49: 4-6mg/kg q24h; < 30 : 6mg/kg q48h |
|||
Linezolid |
– |
600mg q12h |
600mg q12h |
600mg q12h |
||
Teicoplanin |
I |
6mg/kg q24h |
6mg/kg q48h |
6mg/kg q72h |
||
TMP-SMX |
I |
5-20mg/kg/d q6-12h |
30-50: 5-20 mg/kg q6-12h 10-29: 5-10 mg/kg q12h |
Not recommended |
||
Vancomycin |
D, I |
15-30mg/kg q12h |
15mg/kg q24-96h |
7.5mg/kg Q2-3d |
||
Antifungal |
||||||
Fluconazole |
D |
100-400mg q24h% |
50-200mg q24h |
50-200mg q24h |
||
Itraconazole |
D |
200mg q12h |
Do not IV if CrCl < 30 due to accumulation of cyclodextrin vehicle. |
|||
Metronidazole |
D |
7.5mg/kg q6h |
7.5mg/kg q6h |
7.5mg/kg q12h |
||
Voriconazole |
I |
6mg/kg IV 12h*2doses, then 4mg/kg q12h |
If CrCl <50, IV vehicle (cyclodextrin) accumulates. Use oral or discontinue. |
|||
Antituberculous |
||||||
Ethambutol |
I |
15-25mg/kg q24h |
30-50: 15-25mg/kg q24-36h 10-30: 15-25mg/kg q36-48h |
15mg/kg q48h |
||
Isoniazid |
D |
5mg/kg q24h |
5mg/kg q24h |
5mg/kg q24h |
||
Pyrazinamide |
D |
25mg/kg q24h |
21-50: 25mg/kg q24h; 10-20: 25mg/kg q48h; |
25mg/kg q48h |
||
Rifabutin |
D |
300mg q24h |
300mg q24h |
300mg q24h |
||
Rifampin |
D |
600mg q24h |
300-600mg q24h |
300-600mg q24h |
||
Antiviral agents |
||||||
Abacavir |
PO |
600mg q24h |
600mg q24h |
600mg q24h |
||
Acyclovir |
D, I |
5-12.5mg/kg q8h |
5-12.5mg/kg q12-24h |
2.5-6.25mg q24h |
||
Adefovir |
I |
10mg q24h |
10mg q48-72h |
10mg q72h |
||
Amantadine |
I |
100mg q12h |
100mg q24-48h |
100mg weekly |
||
Atripla |
I |
1 tab q24h |
Do not use |
Do not use |
||
Combivir |
PO |
1 tab q12h |
Do not use |
Do not use |
||
Didanosine |
D |
400mg EC q24h |
125-200mg EC q24h |
Do not use |
||
Entecavir |
D |
0.5mg q24h |
0.15-0.25mg q24h |
0.05mg q24h |
||
Famciclovir |
D, I |
500mg q8h |
500mg q12-24h |
250mg q24h |
||
Ganciclovir (IV induction) |
D, I |
70-90: 5mg/kg q12h 50-69: 2.5mg/kg q12h |
25-49: 2.5mg/kg q24h; 10-24: 1.25mg/kg q24h |
1.25mg/kg 3x/week |
||
Ganciclovir (IV maintenence) |
D, I |
2.5-5mg/kg q24h |
0.625-1.25mg/kg q24h |
0.625mg/kg 3x/week |
||
Ganciclovir |
D, I |
0.5-1g q8h |
0.5-1g q24h |
0.5g 3x/week |
||
Lamivudine |
D, I |
300mg q24h |
50-150 mg q24h |
25-50 mg q24h |
||
Oseltamivir |
I |
>60: 75mg q12h |
31-60: 30mg bid; 10- 30: 30mg qd |
Not recommended |
||
Ribavirin |
No dosage adjustment |
Use with caution |
Use with caution |
|||
Sofosbuvir |
PO |
400mg q24h |
Use with caution (no data for use in patients with CrCl<30) |
|||
Stavudine |
D, I |
30-40mg q12h |
15-20mg q12h |
≧ 60 kg: 20mg q24h; < 60 kg: 15mg q24h |
||
Telbivudine |
I |
600mg q24h |
30-49: 600mg q48h; 10-30: 600mg q72h |
600mg q96h |
||
Valaciclovir |
D, I |
1g q8h |
1g q12-24h |
0.5g q24h |
||
D: dosage reduction; I: intervals extension; AD: after dialysis; PO: orally.
Reference: Gilbert DN, et al. eds. The Sanford Guide to Antimicrobial therapy, 46th ed. VA: Antimicrobial Therapy, Inc. 2016; 215–227.